S. Belli

Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer

C. Quintavalle, G. Condorelli, M. Stoppelli, 2022, Molecular therapy. Nucleic acids.

Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins

G. Di Minno, S. Del Vecchio, R. Fonti, 2018, International journal of molecular sciences.

Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides

E. Novellino, P. Grieco, D. Brancaccio, 2020, Cancers.

RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges.

R. Bianco, L. Formisano, R. Ferrara, 2022, Biochimica et biophysica acta. Reviews on cancer.

Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.

R. Bianco, L. Formisano, F. Crocetto, 2023, Cancer treatment reviews.

Paracrine recruitment and activation of fibroblasts by c‐Myc expressing breast epithelial cells through the IGFs/IGF‐1R axis

G. Botti, I. Iaccarino, M. Stoppelli, 2019, International journal of cancer.

c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?

R. Bianco, L. Formisano, A. Servetto, 2020, Cancers.

CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer

J. Herranz, A. Guerrero-Zotano, R. Bianco, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer

R. Bianco, N. Zambrano, T. Troiani, 2023, British Journal of Cancer.

Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer

R. Bianco, L. Formisano, A. Servetto, 2023, NPJ breast cancer.